García-Sáinz J A, Juárez-Ayala J
Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico D.F.
Eur J Pharmacol. 1988 Feb 9;146(2-3):193-9. doi: 10.1016/0014-2999(88)90292-0.
Phorbol 12-myristate 13-acetate (PMA) did not alter the basal cyclic AMP accumulation or lipolysis in isolated rat fat cells. Similarly, PMA was unable to modify the cyclic AMP accumulation induced by isoprenaline and forskolin or the inhibition of cyclic AMP accumulation and lipolysis induced by prostaglandin E2 and phenylisopropiladenosine. PMA inhibited the alpha 1-adrenergic increase in the labeling of phosphatidylinositol in a dose-dependent fashion. By itself, PMA was without significant effect on the labeling of phosphatidylinositol and phosphatidylethanolamine but increased the labeling of phosphatidylcholine and its precursor phosphatidic acid.
佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)不会改变分离的大鼠脂肪细胞中的基础环磷酸腺苷积累或脂解作用。同样,PMA无法改变异丙肾上腺素和福斯高林诱导的环磷酸腺苷积累,也无法改变前列腺素E2和苯异丙基腺苷诱导的环磷酸腺苷积累和脂解作用的抑制。PMA以剂量依赖的方式抑制α1 - 肾上腺素能受体引起的磷脂酰肌醇标记增加。PMA本身对磷脂酰肌醇和磷脂酰乙醇胺的标记没有显著影响,但增加了磷脂酰胆碱及其前体磷脂酸的标记。